Copyright © 2005, European Society of Cardiology
Urocortin II enhances contractility in rabbit ventricular myocytes via CRF2 receptor-mediated stimulation of protein kinase A
aDepartment of Molecular Neuroendocrinology, Max Planck Institute for Experimental Medicine, Hermann-Rein-Str. 3, D-37075 Göttingen, Germany
bDepartment of Cardiology and Pneumology, Georg-August-Universität Göttingen, Robert-Koch-Str. 40, D-37075 Göttingen, Germany
* Corresponding author. Tel.: +49 551 3899 308; fax: +49 551 3899 359. Email address: spiess{at}em.mpg.de
Objective: Urocortin II (UcnII), a peptide of the corticotropin-releasing factor (CRF) family, exerts profound actions on the cardiovascular system. Direct effects of UcnII on adult cardiomyocytes have not been evaluated before. Our aim was to characterize functional effects of UcnII on cardiomyocytes and to elucidate the underlying signaling pathway(s) and cellular mechanisms.
Methods: Rabbit ventricular cardiomyocytes were stimulated at 0.5 Hz (22–25 °C). Unloaded cell shortening (FS, edge detection), [Ca2+]i transients (Fluo-4), and L-type Ca2+ currents (ICa, whole-cell patch clamping) were measured. Sarcoplasmic reticulum (SR) Ca2+ load was assessed by rapid application of caffeine (20 mmol/L).
Results: UcnII increased cell shortening and accelerated relaxation in a time- and concentration-dependent manner (EC50: 10.7 nmol/L). The inotropic effect of UcnII was maximal at 100 nmol/L (35% ± 11% increase in FS, n=8, P<0.05). The inotropic and lusitropic actions of UcnII were largely eliminated by inhibition of CRF2 receptors (10 nmol/L antisauvagine-30, n=5) or protein kinase A (PKA, 500 nmol/L H-89, n=5). UcnII increased [Ca2+]i transient amplitude (by 63% ± 35%, n=7, P<0.05) and decreased the time constant for decay (from 800 ± 63 to 218 ± 27 ms, n=7, P<0.001). UcnII also increased SR Ca2+ load (by 19% ± 7%, n=7, P<0.05) and fractional Ca2+ release (from 57% ± 7% to 98% ± 2%, n=7, P<0.01). ICa was augmented by 32.7% ± 10.0% (n=9, P<0.05) and the ICa–V relationship was shifted by –15 mV during UcnII treatment.
Conclusion: UcnII exerts positive inotropic and lusitropic effects in cardiomyocytes via CRF2 receptor-mediated stimulation of PKA which augments ICa and SR Ca2+ load to increase SR Ca2+ release and [Ca2+]i transients.
KEYWORDS Peptide hormones; Myocytes; E–c coupling; Protein kinase A; SR (function)
1 These authors contributed equally to this work.
Time for primary review 17 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Calderon-Sanchez, C. Delgado, G. Ruiz-Hurtado, A. Dominguez-Rodriguez, V. Cachofeiro, M. Rodriguez-Moyano, A. M. Gomez, A. Ordonez, and T. Smani Urocortin induces positive inotropic effect in rat heart Cardiovasc Res, September 1, 2009; 83(4): 717 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Davis, C. J. Pemberton, T. G. Yandle, S. F. Fisher, J. G. Lainchbury, C. M. Frampton, M. T. Rademaker, and M. Richards Urocortin 2 infusion in human heart failure Eur. Heart J., November 1, 2007; 28(21): 2589 - 2597. [Abstract] [Full Text] [PDF]
|
|